The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 09, 2021
Filed:
Apr. 16, 2019
Applicant:
Apellis Pharmaceuticals, Inc., Crestwood, KY (US);
Inventors:
Cedric Francois, Prospect, KY (US);
Pascal Deschatelets, Prospect, KY (US);
Monica Gerber, Somerville, MA (US);
Assignee:
Apellis Pharmaceuticals, Inc., Waltham, MA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/12 (2006.01); C07K 7/64 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); A61K 47/64 (2017.01); C07K 14/005 (2006.01); C07K 14/475 (2006.01); C12N 7/00 (2006.01); G01N 33/564 (2006.01);
U.S. Cl.
CPC ...
C07K 7/64 (2013.01); A61K 47/645 (2017.08); C07K 7/08 (2013.01); C07K 14/005 (2013.01); C07K 14/472 (2013.01); C07K 14/475 (2013.01); C12N 7/00 (2013.01); G01N 33/564 (2013.01); A61K 38/00 (2013.01); C07K 2319/01 (2013.01); C07K 2319/10 (2013.01); C12N 2740/16022 (2013.01); C12N 2740/16033 (2013.01); G01N 2333/4716 (2013.01);
Abstract
In some aspects, the present invention cell-penetrating compstatin analog and compositions comprising cell-penetrating compstatin analog. In some aspects, the invention further provides methods of using cell-penetrating compstatin analogs treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ, to inhibit production or release of biologically active C3 cleavage products.